Betaxolol is a selective beta-1 adrenergic receptor blocker primarily used in cardiovascular and ophthalmic therapy. It works by reducing the effects of adrenaline on the heart, leading to a decrease in heart rate and blood pressure. Betaxolol is commonly prescribed for the management of hypertension. In ophthalmology, it is used as eye drops to lower intraocular pressure in patients with glaucoma. Unlike non-selective beta blockers, it has minimal effect on beta-2 receptors, making it safer for patients with respiratory conditions. Betaxolol helps reduce the risk of cardiovascular complications associated with high blood pressure. It improves cardiac efficiency by decreasing myocardial oxygen demand. The drug is well tolerated when used as directed. It is available in both oral and ophthalmic formulations. Betaxolol remains an important medication in long-term cardiovascular and eye care.
